nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.0141	0.0143	CcSEcCtD
Ceftibuten—Rigors—Salbutamol—chronic obstructive pulmonary disease	0.0138	0.0139	CcSEcCtD
Ceftibuten—Melaena—Formoterol—chronic obstructive pulmonary disease	0.0116	0.0118	CcSEcCtD
Ceftibuten—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.0116	0.0118	CcSEcCtD
Ceftibuten—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.0114	0.0115	CcSEcCtD
Ceftibuten—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.0114	0.0115	CcSEcCtD
Ceftibuten—Eructation—Salbutamol—chronic obstructive pulmonary disease	0.011	0.0112	CcSEcCtD
Ceftibuten—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.0108	0.011	CcSEcCtD
Ceftibuten—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.0102	0.0103	CcSEcCtD
Ceftibuten—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.01	0.0102	CcSEcCtD
Ceftibuten—Dehydration—Tiotropium—chronic obstructive pulmonary disease	0.00995	0.0101	CcSEcCtD
Ceftibuten—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.0098	0.00993	CcSEcCtD
Ceftibuten—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00948	0.00961	CcSEcCtD
Ceftibuten—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00948	0.00961	CcSEcCtD
Ceftibuten—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00895	0.00907	CcSEcCtD
Ceftibuten—Cefdinir—MPO—chronic obstructive pulmonary disease	0.00894	0.674	CrCbGaD
Ceftibuten—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00865	0.00877	CcSEcCtD
Ceftibuten—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00834	0.00845	CcSEcCtD
Ceftibuten—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00811	0.00822	CcSEcCtD
Ceftibuten—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00807	0.00818	CcSEcCtD
Ceftibuten—Dehydration—Arformoterol—chronic obstructive pulmonary disease	0.00803	0.00814	CcSEcCtD
Ceftibuten—Dehydration—Formoterol—chronic obstructive pulmonary disease	0.00803	0.00814	CcSEcCtD
Ceftibuten—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00778	0.00789	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00762	0.00772	CcSEcCtD
Ceftibuten—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00756	0.00767	CcSEcCtD
Ceftibuten—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00736	0.00746	CcSEcCtD
Ceftibuten—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00727	0.00737	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00722	0.00732	CcSEcCtD
Ceftibuten—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00721	0.00731	CcSEcCtD
Ceftibuten—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00715	0.00725	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00684	0.00693	CcSEcCtD
Ceftibuten—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00664	0.00673	CcSEcCtD
Ceftibuten—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00661	0.0067	CcSEcCtD
Ceftibuten—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00659	0.00668	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00646	0.00655	CcSEcCtD
Ceftibuten—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00635	0.00644	CcSEcCtD
Ceftibuten—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00635	0.00643	CcSEcCtD
Ceftibuten—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00635	0.00643	CcSEcCtD
Ceftibuten—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00628	0.00636	CcSEcCtD
Ceftibuten—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00616	0.00624	CcSEcCtD
Ceftibuten—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00613	0.00621	CcSEcCtD
Ceftibuten—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.006	0.00608	CcSEcCtD
Ceftibuten—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00599	0.00607	CcSEcCtD
Ceftibuten—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00592	0.006	CcSEcCtD
Ceftibuten—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00572	0.0058	CcSEcCtD
Ceftibuten—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00567	0.00575	CcSEcCtD
Ceftibuten—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00564	0.00572	CcSEcCtD
Ceftibuten—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00558	0.00565	CcSEcCtD
Ceftibuten—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00553	0.00561	CcSEcCtD
Ceftibuten—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00553	0.00561	CcSEcCtD
Ceftibuten—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00537	0.00544	CcSEcCtD
Ceftibuten—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00532	0.00539	CcSEcCtD
Ceftibuten—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00532	0.00539	CcSEcCtD
Ceftibuten—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00527	0.00534	CcSEcCtD
Ceftibuten—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00527	0.00534	CcSEcCtD
Ceftibuten—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00524	0.00531	CcSEcCtD
Ceftibuten—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00509	0.00516	CcSEcCtD
Ceftibuten—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00509	0.00516	CcSEcCtD
Ceftibuten—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00506	0.00513	CcSEcCtD
Ceftibuten—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00504	0.00511	CcSEcCtD
Ceftibuten—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00497	0.00503	CcSEcCtD
Ceftibuten—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00491	0.00498	CcSEcCtD
Ceftibuten—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00485	0.00491	CcSEcCtD
Ceftibuten—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00484	0.0049	CcSEcCtD
Ceftibuten—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00481	0.00487	CcSEcCtD
Ceftibuten—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00478	0.00484	CcSEcCtD
Ceftibuten—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00478	0.00484	CcSEcCtD
Ceftibuten—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00476	0.00482	CcSEcCtD
Ceftibuten—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00472	0.00479	CcSEcCtD
Ceftibuten—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00468	0.00474	CcSEcCtD
Ceftibuten—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00463	0.00469	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00456	0.00462	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00454	0.0046	CcSEcCtD
Ceftibuten—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00451	0.00457	CcSEcCtD
Ceftibuten—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0045	0.00456	CcSEcCtD
Ceftibuten—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00443	0.00449	CcSEcCtD
Ceftibuten—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00441	0.00447	CcSEcCtD
Ceftibuten—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00441	0.00447	CcSEcCtD
Ceftibuten—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00441	0.00447	CcSEcCtD
Ceftibuten—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00433	0.00439	CcSEcCtD
Ceftibuten—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00433	0.00439	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0043	0.00436	CcSEcCtD
Ceftibuten—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00424	0.0043	CcSEcCtD
Ceftibuten—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00424	0.0043	CcSEcCtD
Ceftibuten—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00418	0.00423	CcSEcCtD
Ceftibuten—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00416	0.00421	CcSEcCtD
Ceftibuten—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00416	0.00421	CcSEcCtD
Ceftibuten—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.00416	CcSEcCtD
Ceftibuten—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00409	0.00414	CcSEcCtD
Ceftibuten—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00408	0.00414	CcSEcCtD
Ceftibuten—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00401	0.00406	CcSEcCtD
Ceftibuten—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00395	0.004	CcSEcCtD
Ceftibuten—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00388	0.00393	CcSEcCtD
Ceftibuten—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00384	0.00389	CcSEcCtD
Ceftibuten—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00384	0.00389	CcSEcCtD
Ceftibuten—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00382	0.00387	CcSEcCtD
Ceftibuten—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00382	0.00387	CcSEcCtD
Ceftibuten—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00378	0.00384	CcSEcCtD
Ceftibuten—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00378	0.00384	CcSEcCtD
Ceftibuten—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00377	0.00382	CcSEcCtD
Ceftibuten—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00377	0.00382	CcSEcCtD
Ceftibuten—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00376	0.00381	CcSEcCtD
Ceftibuten—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00374	0.00379	CcSEcCtD
Ceftibuten—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00374	0.00379	CcSEcCtD
Ceftibuten—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00373	0.00378	CcSEcCtD
Ceftibuten—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00372	0.00377	CcSEcCtD
Ceftibuten—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0037	0.00375	CcSEcCtD
Ceftibuten—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00369	0.00374	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00366	0.00371	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00366	0.00371	CcSEcCtD
Ceftibuten—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00366	0.00371	CcSEcCtD
Ceftibuten—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00366	0.00371	CcSEcCtD
Ceftibuten—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00366	0.00371	CcSEcCtD
Ceftibuten—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00363	0.00368	CcSEcCtD
Ceftibuten—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00363	0.00368	CcSEcCtD
Ceftibuten—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00367	CcSEcCtD
Ceftibuten—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.0036	0.00365	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00359	0.00364	CcSEcCtD
Ceftibuten—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00358	0.00363	CcSEcCtD
Ceftibuten—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00357	0.00362	CcSEcCtD
Ceftibuten—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00361	CcSEcCtD
Ceftibuten—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00355	0.00359	CcSEcCtD
Ceftibuten—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00353	0.00358	CcSEcCtD
Ceftibuten—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00352	0.00356	CcSEcCtD
Ceftibuten—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00351	0.00356	CcSEcCtD
Ceftibuten—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00349	0.00354	CcSEcCtD
Ceftibuten—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00348	0.00353	CcSEcCtD
Ceftibuten—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00352	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00347	0.00352	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00347	0.00352	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00351	CcSEcCtD
Ceftibuten—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.0035	CcSEcCtD
Ceftibuten—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.00347	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0034	0.00345	CcSEcCtD
Ceftibuten—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00337	0.00342	CcSEcCtD
Ceftibuten—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00337	0.00342	CcSEcCtD
Ceftibuten—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00336	0.0034	CcSEcCtD
Ceftibuten—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00336	0.0034	CcSEcCtD
Ceftibuten—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00336	0.0034	CcSEcCtD
Ceftibuten—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00336	0.0034	CcSEcCtD
Ceftibuten—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00334	0.00339	CcSEcCtD
Ceftibuten—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00332	0.00336	CcSEcCtD
Ceftibuten—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00332	0.00336	CcSEcCtD
Ceftibuten—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00331	0.00336	CcSEcCtD
Ceftibuten—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00331	0.00336	CcSEcCtD
Ceftibuten—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.0033	0.00335	CcSEcCtD
Ceftibuten—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0033	0.00334	CcSEcCtD
Ceftibuten—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00329	0.00333	CcSEcCtD
Ceftibuten—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00329	0.00333	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00328	0.00332	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00325	0.0033	CcSEcCtD
Ceftibuten—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00324	0.00329	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00324	0.00328	CcSEcCtD
Ceftibuten—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00318	0.00323	CcSEcCtD
Ceftibuten—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00317	0.00321	CcSEcCtD
Ceftibuten—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00317	0.00321	CcSEcCtD
Ceftibuten—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00313	0.00317	CcSEcCtD
Ceftibuten—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00313	0.00317	CcSEcCtD
Ceftibuten—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00312	0.00317	CcSEcCtD
Ceftibuten—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00306	0.0031	CcSEcCtD
Ceftibuten—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00305	0.00309	CcSEcCtD
Ceftibuten—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00305	0.00309	CcSEcCtD
Ceftibuten—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.003	0.00304	CcSEcCtD
Ceftibuten—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.003	0.00304	CcSEcCtD
Ceftibuten—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00298	0.00302	CcSEcCtD
Ceftibuten—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00299	CcSEcCtD
Ceftibuten—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00294	0.00298	CcSEcCtD
Ceftibuten—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00294	CcSEcCtD
Ceftibuten—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00294	CcSEcCtD
Ceftibuten—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00288	0.00291	CcSEcCtD
Ceftibuten—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00288	CcSEcCtD
Ceftibuten—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00287	CcSEcCtD
Ceftibuten—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00284	CcSEcCtD
Ceftibuten—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00284	CcSEcCtD
Ceftibuten—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00279	CcSEcCtD
Ceftibuten—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00275	0.00278	CcSEcCtD
Ceftibuten—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00278	CcSEcCtD
Ceftibuten—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00274	CcSEcCtD
Ceftibuten—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00274	CcSEcCtD
Ceftibuten—Rash—Formoterol—chronic obstructive pulmonary disease	0.00268	0.00271	CcSEcCtD
Ceftibuten—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00268	0.00271	CcSEcCtD
Ceftibuten—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00267	0.00271	CcSEcCtD
Ceftibuten—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00267	0.00271	CcSEcCtD
Ceftibuten—Headache—Formoterol—chronic obstructive pulmonary disease	0.00266	0.0027	CcSEcCtD
Ceftibuten—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00266	0.0027	CcSEcCtD
Ceftibuten—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00269	CcSEcCtD
Ceftibuten—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00264	0.00268	CcSEcCtD
Ceftibuten—Rash—Montelukast—chronic obstructive pulmonary disease	0.00262	0.00266	CcSEcCtD
Ceftibuten—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00262	0.00265	CcSEcCtD
Ceftibuten—Headache—Montelukast—chronic obstructive pulmonary disease	0.0026	0.00264	CcSEcCtD
Ceftibuten—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00258	CcSEcCtD
Ceftibuten—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.00256	CcSEcCtD
Ceftibuten—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Ceftibuten—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Ceftibuten—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Ceftibuten—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00254	CcSEcCtD
Ceftibuten—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00247	0.0025	CcSEcCtD
Ceftibuten—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00244	0.00247	CcSEcCtD
Ceftibuten—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00241	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00236	0.0024	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00235	0.00238	CcSEcCtD
Ceftibuten—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.0023	0.174	CrCbGaD
Ceftibuten—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.0023	0.00233	CcSEcCtD
Ceftibuten—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00208	0.00211	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00209	CcSEcCtD
Ceftibuten—Cefalotin—ALB—chronic obstructive pulmonary disease	0.00202	0.152	CrCbGaD
Ceftibuten—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00188	0.00191	CcSEcCtD
Ceftibuten—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00185	CcSEcCtD
Ceftibuten—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00177	0.0018	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00172	CcSEcCtD
Ceftibuten—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00169	CcSEcCtD
Ceftibuten—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00161	CcSEcCtD
Ceftibuten—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00154	CcSEcCtD
Ceftibuten—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00152	CcSEcCtD
Ceftibuten—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00147	0.00149	CcSEcCtD
Ceftibuten—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Ceftibuten—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Ceftibuten—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Ceftibuten—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00146	CcSEcCtD
Ceftibuten—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00146	CcSEcCtD
Ceftibuten—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00145	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Ceftibuten—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Ceftibuten—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00134	CcSEcCtD
Ceftibuten—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Ceftibuten—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00125	CcSEcCtD
Ceftibuten—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00121	CcSEcCtD
Ceftibuten—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Ceftibuten—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00116	CcSEcCtD
Ceftibuten—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00112	CcSEcCtD
Ceftibuten—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00108	CcSEcCtD
Ceftibuten—Rash—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00107	CcSEcCtD
Ceftibuten—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00107	CcSEcCtD
Ceftibuten—Headache—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00106	CcSEcCtD
Ceftibuten—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000992	0.00101	CcSEcCtD
